Michigan Supreme Court rules in favor of insurance company denying coverage for stem cell surgery

Stem cell research is a controversial issue. While the issue is primarily comprised of its uses in medicine, the controversy extends well into the insurance industry. As new methods of treatment emerge, insurance companies must weigh the risks involved with such treatments and what implications could be made to their policies. Most insurers cringe away from covering medical procedures that have a limited history of use, arguing that the risks involved with such things as stem cell surgeries are immeasurable. The fears insurers harbor over the issue may have been…

Read More